InsiderTrades

Form 4 for CELU Celularity Inc

Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-13 · accession 0001641172-25-004821 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-04-15 2025-04-13 CELU Brigido Stephen Pres, Functional Regeneration F - Tax $1.64 -268 8,921 -3% -$439.52
D 2025-04-15 2025-04-13 CELU Brigido Stephen Pres, Functional Regeneration M - OptEx $0.00 +820 9,189 +10% $0
D 2025-04-15 2025-04-13 CELU Brigido Stephen Pres, Functional Regeneration M - OptEx $0.00 -820 820 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-04-13 F D 268 $1.64 8,921 D — —
2 Common Class A Common Stock 2025-04-13 M A 820 $0.00 9,189 D — —
3 Derivative Restricted Stock Units 2025-04-13 M D 820 $0.00 820 D — · — to — 820 Class A Common Stock (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On April 13, 2022, the reporting person was granted 3,281 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.